← Back

Wire · opportunities

Dental AI company earns FDA clearance for 3D CBCT imaging software

Published

27 July 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at beckersdental.com

Verified

Fusion42 · 27 July 2026 · Fusion42 review

Velmeni has received FDA 510(k) clearance for AI-powered 3D cone beam computed tomography (CBCT) dental imaging software that enables anatomical segmentation, visualization, measurements and image reconstruction. The software supports implant planning, endodontic assessment, orthodontic evaluation, surgical review and airway analysis as part of a broader connected AI dental platform.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

FDA has now cleared AI-powered 3D dental imaging as a predicate category, meaning competitors can follow faster through 510(k) rather than waiting for de novo review. If you're building diagnostic AI for dental or maxillofacial imaging, the regulatory path just compressed from 18-24 months to 6-8 months.

Related on Wire

Topics

Medtechfda-clearancedental-aimedical-imagingregulatory-approvalcbct-segmentation
Dental AI company earns FDA clearance for 3D CBCT ima… | Fusion42